Posted by Michael Wonder on 31 Jan 2021
Medicines Australia’s position on potential European Union restrictions and vaccines supply
30 January 2021 - Medicines Australia is concerned by the reports of proposals from Europe that could impact the global supply chains of COVID-19 vaccines.
Maintaining global supply chains is a top priority for the medicines industry and is key to delivering vaccines to protect citizens against COVID-19.
The making of a vaccine requires many dozens of ingredients and manufacturing components which come from multiple sources around the world.
